Skip to content
  • Home
  • CONGRESS INFORMATION
    • Welcome Letter
    • Congress Chair
    • General information
    • Virtual Congress
    • Target Audience
  • AGENDA
    • CONGRESS AGENDA
    • Speakers
  • ABSTRACTS
    • Call for Abstracts
    • Abstract Topics
  • REGISTRATION
    • Registration
    • Group Registration
  • SPONSORSHIP/EXHIBITION
    • Sponsorship Levels & Benefits
    • Sponsors & Exhibitors
    • Italian Sponsors
  • Contact Us

The Virtual Congress on

Controversies in Leukemias

29-30 October 2020
  • Home
  • CONGRESS INFORMATION
    • Welcome Letter
    • Congress Chair
    • General information
    • Virtual Congress
    • Target Audience
  • AGENDA
    • CONGRESS AGENDA
    • Speakers
  • ABSTRACTS
    • Call for Abstracts
    • Abstract Topics
  • REGISTRATION
    • Registration
    • Group Registration
  • SPONSORSHIP/EXHIBITION
    • Sponsorship Levels & Benefits
    • Sponsors & Exhibitors
    • Italian Sponsors
  • Contact Us

Incyte

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Since 2002, Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders. The Company is advancing a diversified portfolio of clinical candidates across two franchises: Oncology and Inflammation & Autoimmunity.

Headquartered in Wilmington, Delaware, Incyte has operations in the U.S., Canada, Europe and Japan.

 

#EuroLeuk2020

Join our online community:
Contact Us

US:       +1-857-400-0035
UK:      +44-203-051-4032
Email:  info@bioevents-congress.com

Copyright © 2015 BioEvents.net. All Rights Reserved
Term Of Use
Privacy Policy
Powered By Form Wizard
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Necessary Always Enabled